Affiliation:
1. Department of Pharmacology , AIIMS Bhopal , Bhopal , Madhya Pradesh , India
2. Department of Pharmacology , Kalpana Chawla Government Medical College , Karnal , India
Abstract
Abstract
After healing from COVID-19, patients often experience a slew of symptoms known as post COVID-19 sequelae. Despite the fact that the SARS-CoV-2 pandemic is still ongoing, post-Covid-19 syndrome is already a difficult problem to address: long-term multiorgan sequelae, while frequently described, have yet to be systematized. As a result, post-Covid-19 syndrome can have a major influence on surviving patients’ working capacity as well as their personal lives. The clinical spectrum and long-term course of this clinical entity must be better understood. Post-Covid syndrome affects a wide spectrum of individuals (16–87%), with pneumological and cognitive symptoms being the most common. Pulmonary fibrosis was the most common organic consequence seen in post-Covid patients. In conclusion, post-Covid-19 syndrome can have a major impact on the health of survivors. Working-age patients should seek rehabilitation and follow-up in interdisciplinary rehabilitation programmes. Given the pandemic’s global extent, it’s obvious that COVID-19-related healthcare demands will continue to climb for the foreseeable future. For COVID-19 survivors’ long-term mental and physical health, present outpatient infrastructure will be utilised, scalable healthcare models will be built, and cross-disciplinary collaboration will be required.
Subject
Drug Discovery,Pharmacology,General Medicine,Physiology
Reference111 articles.
1. World health organization (WHO). [Homepage in Internet] Director-General’s opening remarks at the media briefing on COVID-19; 2020. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020. [Accessed 25 Sep 2020].
2. Bansal, M. Cardiovascular disease and COVID-19. Diabetes Metabol Syndr 2020;14:247–50. https://doi.org/10.1016/j.dsx.2020.03.013.
3. Zheng, J. SARS-CoV-2: an emerging coronavirus that causes a global threat. Int J Biol Sci 2020;16:1678–85. https://doi.org/10.7150/ijbs.45053.
4. Hamming, I, Timens, W, Bulthuis, ML, Lely, AT, Navis, G, van Goor, H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 2004;203:631–7. https://doi.org/10.1002/path.1570.
5. MoHFW [Home page on Internet]. Available from: https://www.mohfw.gov.in/. [Accessed 4 Jan 2021].
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献